BREA KILPATRICK: Open Payments
NPI 1003558362 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,256 in 75 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $243 · 2025 $1,256
Food & beverage: $1,256
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $380 |
| E.R. Squibb & Sons, L.L.C. | 10 | $184 |
| Janssen Pharmaceuticals, Inc | 8 | $165 |
| Vanda Pharmaceuticals Inc. | 8 | $137 |
| Neurocrine BioSciences, Inc. | 3 | $75 |
| Indivior Inc. | 3 | $70 |
| Bausch Health US, LLC | 2 | $46 |
| Alkermes, Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $36 |
Products named: VRAYLAR, COBENFY, SPRAVATO, HETLIOZ, INGREZZA, SUBLOCADE, ARISTADA, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
